BioNexus Gene Lab (BGLC) Inventory (2018 - 2026)

BioNexus Gene Lab has disclosed Inventory across 9 years of filings, most recently posting $652892.0 for Q2 2026.

• In Q2 2026, Inventory fell 46.29% year-over-year to $652892.0; the TTM figure through Jun 2026 stood at $652892.0 (down 46.29% YoY), while the FY2025 annual figure was $676703.0, down 51.27% from the prior year.
• Inventory came in at $652892.0 for Q2 2026 at BioNexus Gene Lab, down from $667154.0 in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.6 million in Q1 2022 to a low of $652892.0 in Q2 2026.
• Average Inventory over 5 years is $1.1 million, with a median of $1.1 million recorded in 2022.
• Year-over-year, Inventory climbed 25.38% in 2024 and tumbled 51.27% in 2025.
• Over 5 years, Inventory stood at $977807.0 in 2022, then grew by 16.36% to $1.1 million in 2023, then gained by 22.05% to $1.4 million in 2024, then plunged by 51.27% to $676703.0 in 2025, then decreased by 3.52% to $652892.0 in 2026.
• Per Business Quant data, the three most recent Inventory figures were $652892.0 in Q2 2026, $667154.0 in Q1 2026, and $676703.0 in Q4 2025.